Inventor · disambiguated record
Hideo Tsurushima
Also filed as: TSURUSHIMA HIDEO
1 granted patent·7 pending applications·0 citations·filing 2004–2023
2Inventor score
Top patents by PatentIndex Score
8 records- 0168US2024008804A1Body fluid volume estimation device, body fluid volume estimation method, and non-transitory computer-readable mediumNEC CORP·Filed 2023·Application pending·0 cites
- 0268US2024008806A1Body fluid volume estimation device, body fluid volume estimation method, and non-transitory computer-readable mediumNEC CORP·Filed 2023·Application pending·0 cites
- 0368US2024008805A1Body fluid volume estimation device, body fluid volume estimation method, and non-transitory computer-readable mediumNEC CORP·Filed 2023·Application pending·0 cites
- 0467US2024008803A1Body fluid volume estimation device, body fluid volume estimation method, and non-transitory computer-readable mediumNEC CORP·Filed 2023·Application pending·0 cites
- 0547US12496015B2Disease-condition assessment device, disease-condition assessment method, program for disease-condition assessment device, and disease-condition assessment systemAIST·Filed 2020·Granted Dec 16, 2025·0 cites·24 claims
- 0639US2023174073A1Disease-condition assessment device, disease-condition assessment method, program for disease-condition assessment device, and disease-condition assessment systemAIST·Filed 2021·Application pending·0 cites
- 0737US2007286896A1Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting LiposomeNAT INST OF ADVANCED IND SCIEN·Filed 2004·Application pending·0 cites
- 0837US2007160657A1Targeting and intestinal-absorption controlled liposome having sugar chain and therapeutic drug for cancer and diagnostic drug containing the liposomeNAT INST OF ADVANCED IND SCIEN·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hideo Tsurushima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →